IMMUNE RESPONSE TO HELICOBACTER PYLORI ANTIGENS AND ITS IMPLICATIONS IN GASTRIC PATHOLOGY

Main Article Content

Bazarova Gulnora Rustamovna

Abstract

Helicobacter pylori (H. pylori) is a Gram-negative bacterium with a marked affinity for gastric tissue and is globally recognized as a major cause of gastrointestinal disease. Chronic infection with H. pylori is implicated in a wide spectrum of disorders, including peptic ulcer disease, gastric adenocarcinoma, mucosa-associated lymphoid tissue (MALT) lymphoma, and several extra-gastric complications. The bacterium expresses multiple virulence factors—such as lipopolysaccharides (LPS), cytotoxin-associated gene A (CagA), vacuolating cytotoxin A (VacA), and a range of adhesins—that provoke a strong host immune response during the early stages of infection.

Downloads

Download data is not yet available.

Article Details

Section

Articles

How to Cite

IMMUNE RESPONSE TO HELICOBACTER PYLORI ANTIGENS AND ITS IMPLICATIONS IN GASTRIC PATHOLOGY. (2025). International Bulletin of Medical Sciences and Clinical Research, 5(10), 80-93. https://doi.org/10.37547/

References

1.Warren, J.R.; Marshall, B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, 1, 1273–1275. [Google Scholar] [PubMed]

2.Santacroce, L.; Topi, S.; Bottalico, L.; Charitos, I.A.; Jirillo, E. Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions. Curr. Issues Mol. Biol. 2024, 46, 4991–5009. [Google Scholar] [CrossRef] [PubMed]

3.Suzuki, H.; Moayyedi, P. Helicobacter pylori infection in functional dyspepsia. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 168–174. [Google Scholar] [CrossRef]

4.Ansari, S.; Yamaoka, Y. Survival of Helicobacter pylori in gastric acidic territory. Helicobacter 2017, 22, e12386. [Google Scholar] [CrossRef] [PubMed]

5.Gu, H. Role of Flagella in the Pathogenesis of Helicobacter pylori. Curr. Microbiol. 2017, 74, 863–869. [Google Scholar] [CrossRef]

6.Backert, S.; Tegtmeyer, N.; Fischer, W. Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system. Future Microbiol. 2015, 10, 955–965. [Google Scholar] [CrossRef] [PubMed]

7.Feedings, N.J.; Caston, R.R.; McClain, M.S.; Ohi, M.D.; Cover, T.L. An Overview of Helicobacter pylori VacA Toxin Biology. Toxins 2016, 8, 173. [Google Scholar] [CrossRef]

8.Kusters, J.G.; van Vliet, A.H.; Kuipers, E.J. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19, 449–490. [Google Scholar] [CrossRef]

9.Sukri, A.; Hanafiah, A.; Mohamad Zin, N.; Kosai, N.R. Epidemiology and role of Helicobacter pylori virulence factors in gastric cancer carcinogenesis. APMIS. 2020, 128, 150–161. [Google Scholar] [CrossRef] [PubMed]

10.Lembo, A.; Caradonna, L.; Magrone, T.; Mastronardi, M.L.; Caccavo, D.; Jirillo, E.; Amati, L. Helicobacter pylori organisms induce expression of activation and apoptotic surface markers on human lymphocytes and AGS cells: A cytofluorimetric evaluation. Immunopharmacol. Immunotoxicol. 2002, 24, 567–582. [Google Scholar] [CrossRef]

11.Hynes, S.O.; Ferris, J.A.; Szponar, B.; Wadström, T.; Fox, J.G.; O’Rourke, J.; Larsson, L.; Yaquian, E.; Ljungh, A.; Clyne, M.; et al. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters. Helicobacter 2004, 9, 313–323. [Google Scholar] [CrossRef] [PubMed]

12.Moran, A.P.; Aspinall, G.O. Unique structural and biological features of Helicobacter pylori lipopolysaccharides. Prog. Clin. Biol. Res. 1998, 397, 37–49. [Google Scholar] [PubMed]

13.Miller, S.I.; Ernst, R.K.; Bader, M.W. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 2005, 3, 36–46. [Google Scholar] [CrossRef]

14.Smith MFJr Mitchell, A.; Li, G.; Ding, S.; Fitzmaurice, A.M.; Ryan, K.; Crowe, S.; Goldberg, J.B. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 2003, 278, 32552–32560. [Google Scholar] [CrossRef]

15.Russo, F.; Jirillo, E.; Clemente, C.; Messa, C.; Chiloiro, M.; Riezzo, G.; Amati, L.; Caradonna, L.; Di Leo, A. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol. Immunotoxicol. 2001, 23, 13–24. [Google Scholar] [CrossRef]

16.Bagheri, N.; Azadegan-Dehkordi, F.; Rahimian, G.; Rafieian-Kopaei, M.; Shirzad, H. Role of Regulatory T-cells in Different Clinical Expressions of Helicobacter pylori Infection. Arch. Med. Res. 2016, 47, 245–254. [Google Scholar] [CrossRef] [PubMed]

17.Russo, F.; Messa, C.; Amati, L.; Caradonna, L.; Leoci, C.; Di Matteo, G.; Jirillo, E.; Di Leo, A. The influence of Helicobacter pylori eradication on the gastric mucosal content of epidermal growth factor, transforming growth factor-alpha, and their common receptor. Scand. J. Gastroenterol. 1998, 33, 271–275. [Google Scholar] [CrossRef]

18.Topi, S.; Santacroce, L.; Bottalico, L.; Ballini, A.; Inchingolo, A.D.; Dipalma, G.; Charitos, I.A.; Inchingolo, F. Gastric Cancer in History: A Perspective Interdisciplinary Study. Cancers 2020, 12, 264. [Google Scholar] [CrossRef]

19.Muotiala, A.; Helander, I.M.; Pyhälä, L.; Kosunen, T.U.; Moran, A.P. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 1992, 60, 1714–1716. [Google Scholar] [CrossRef]

20.Moran, A.P.; Lindner, B.; Walsh, E.J. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J. Bacteriol. 1997, 179, 6453–6463. [Google Scholar] [CrossRef]

21.Stead, C.M.; Beasley, A.; Cotter, R.J.; Trent, M.S. Deciphering the unusual acylation pattern of Helicobacter pylori lipid A. J. Bacteriol. 2008, 190, 7012–7021. [Google Scholar] [CrossRef] [PubMed]

22.Freudenberg, M.A.; Galanos, C. Bacterial lipopolysaccharides: Structure, metabolism and mechanisms of action. Int. Rev. Immunol. 1990, 6, 207–221. [Google Scholar] [CrossRef]

23.Mattsby-Baltzer, I.; Mielniczuk, Z.; Larsson, L.; Lindgren, K.; Goodwin, S. Lipid A in Helicobacter pylori. Infect. Immun. 1992, 60, 4383–4387. [Google Scholar] [CrossRef] [PubMed]

24.Appelmelk, B.J.; Negrini, R.; Moran, A.P.; Kuipers, E.J. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 1997, 5, 70–73. [Google Scholar] [CrossRef]

Similar Articles

You may also start an advanced similarity search for this article.